Ineke J.
- Country
- The Netherlands
- Department
- Reproductive medicine and gynecology
Research Overview
Data & Insights
Has run more than one trial at 17 of 35 partner sites.
Specializations
Cardiovascular & Metabolic Therapeutics
The investigator concentrates on atherosclerotic cardiovascular disease, heart rhythm disorders, and metabolic lipid abnormalities that drive major adverse cardiac events.
- ASCVD
- Atrial Fibrillation
- Heart failure
- Lipoprotein(a) lowering
- Hypertriglyceridemia
Efforts span primary prevention, post‑myocardial infarction risk reduction, and novel anti‑inflammatory strategies.
Oncology and Tumor Therapeutics
Work in this area targets aggressive solid malignancies, emphasizing targeted and hormonal strategies for breast, colorectal, and lung cancers.
- Triple‑negative breast cancer
- Metastatic colorectal cancer
- Advanced non‑small cell lung cancer
- Hormone receptor‑positive breast cancer
- Solid tumors
Research supports survival improvement and disease‑specific biomarker integration.
Hematology and Immune‑Mediated Diseases
Focus includes chronic lymphoid malignancies and autoimmune neurologic disorders, aiming to modulate B‑cell activity and neuroinflammation.
- Chronic lymphocytic leukemia
- Small lymphocytic lymphoma
- Multiple sclerosis
- IgA nephropathy
- Relapsed/refractory hematologic malignancies
Investigations address durable remission and disease‑modifying outcomes.
Reproductive Medicine and Gynecologic Therapeutics
In the reproductive sphere the investigator explores causes of infertility and common gynecologic conditions, integrating endocrine and procedural interventions.
- Unexplained infertility
- Polycystic ovary syndrome
- Uterine fibroids
- Ovulation induction
- Intra‑uterine insemination
Goals include optimizing live‑birth rates and symptom relief.
Renal & Kidney Therapeutics
Research addresses chronic kidney impairment and glomerular diseases, linking cardiovascular risk factors with renal outcomes.
- Chronic kidney disease
- IgA nephropathy
- Lipoprotein(a)‑related renal risk
Efforts target slowing progression and reducing cardiovascular‑renal cross‑talk.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.